Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/31851
Title: | Aspirin resistance. | Authors: | Hankey G.J.;Eikelboom J.W.;Tran H.A.;Anand S.S. | Institution: | (Tran) Department of Clinical Haematology, Monash Medical Centre, Clayton, Vic., Australia (Hankey) Department of Neurology, Royal Perth Hospital, University of Western Australia, Australia (Anand, Eikelboom) Department of Medicine, McMaster University, Canada | Issue Date: | 16-Oct-2012 | Copyright year: | 2007 | Publisher: | Elsevier Ltd (Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom) | Place of publication: | United Kingdom | Publication information: | Thrombosis Research. 120 (3) (pp 337-346), 2007. Date of Publication: 2007. | Abstract: | Aspirin resistance refers to less than expected suppression of thromboxane A2 production by aspirin and has been reported to be independently associated with an increased risk of adverse cardiovascular events. Possible causes of aspirin resistance include poor compliance, drug interaction, inadequate aspirin dose, increase turnover of platelets, genetic polymorphisms of cyclo-oxygenase-1, and upregulation of alternate (non-platelet) pathways of thromboxane production. Laboratory methods used to detect aspirin resistance include those that measure thromboxane A2 production and thromboxane A2-dependent platelet function. However, since there is currently no standardised approach to the diagnosis and there are no proven effective treatments for aspirin resistance that improve outcome, patients with cardiovascular disease receiving aspirin should not be routinely tested for aspirin resistance. Instead physicians should be aware of the factors that may impair aspirin function, ensure that they use an appropriate dose of aspirin and optimise compliance with aspirin therapy. Further research exploring the mechanisms of aspirin resistance is needed in order to better define and develop a standardised test for aspirin resistance that is specific, reliable, can be readily applied in routine laboratories and correlate with an increased risk of cardiovascular events. © 2006 Elsevier Ltd. All rights reserved. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.thromres.2006.08.014 | PubMed URL: | 17241655 [http://www.ncbi.nlm.nih.gov/pubmed/?term=17241655] | ISSN: | 0049-3848 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/31851 | Type: | Review | Type of Clinical Study or Trial: | Review article (e.g. literature review, narrative review) |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.